510(k) K232864
K232864 is an FDA 510(k) premarket notification submitted by Nantong Egens Biotechnology Co., Ltd. for the device "EGENS Pregnancy Test Midstream I, EGENS Pregnancy Test Midstream II". The FDA issued a decision of Substantially Equivalent on January 26, 2024. The device falls under product code LCX (Kit, Test, Pregnancy, Hcg, Over The Counter), a Class II device regulated under 21 CFR 862.1155.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 26, 2024
- Date Received
- September 15, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Kit, Test, Pregnancy, Hcg, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.1155
- Review Panel
- CH
- Submission Type